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Synchronous malignancy of squamous cell carcinoma and malignant lymphoma in the head and neck region is extremely rare.
Nasopharyngeal carcinoma is a nonlymphomatous, squamous cell carcinoma that occurs in the nasopharyngeal epithelium.
Reported herein is a unique case of nasopharyngeal carcinoma occurring simultaneously with MALT-type lymphoma in an 83-
year-old woman, who complained of deglutition dysfunction. Endoscopic examination of respective organs revealed a submucosal
tumour on the posterior wall of pharynx. Biopsy of the hypopharynx was taken and sent for histological examination, which
revealed two diﬀerent neoplasms. Immunohistochemical and molecular analysis conﬁrmed the diagnosis of nasopharyngeal
carcinoma coexisting with a MALT-type lymphoma.
1.Introduction
Nasopharyngeal carcinoma is a squamous cell carcinoma
that occurs in the epithelium of nasopharyngeal mucosa and
has been strongly associated with EBV presence. Signs and
symptoms are often subtle and nonspeciﬁc and thereby may
cause a delay in diagnosis, resulting in clinical presentation
at an advanced stage of disease.
M A L T - t y p el y m p h o m ai sal o w - g r a d em a r g i n a lz o n eB -
cell lymphoma aﬀecting various extranodal sites such as
mucosal surfaces and parenchymatous organs [1]. MALT-
type lymphomas have been noted to arise at diﬀerent sites
of the head and neck region including ocular adnexae,
major salivary glands, oral cavity, tonsils, nasopharynx,
oropharynx, hypopharynx, larynx, and thyroid gland [2].
Hypopharyngeal involvement is uncommon in comparison
totheothersitesoftheheadandneckarea[3,4].MALT-type
lymphoma of the head and neck often presents diagnostic
and therapeutic challenges [5, 6].
Taking all the available references into consideration,
coexistence of these two diﬀerent neoplasms has never been
reported. Moreover, because of the fact that nasopharyn-
geal nonkeratinizing carcinoma may have a rich reactive
lymphoid substrate, the presence of MALT-type lymphoma
may be passed over. Thus, pathologists should be aware
of this concurrent neoplasm existence in order to avoid
misinterpretation.
2. ClinicalHistory
An 83-year-old Caucasian female patient presented with a
six-month history of swallowing discomfort and throat pain.
On nasopharyngolaryngoscopic examination, a nonulcera-
tive submucosal tumour on the posterior pharyngeal wall
was revealed. On MRI images of the head and neck area,
a large soft tissue mass of nasopharynx (left and right)
was noted (Figure 1), which extended to oropharynx and
hypopharynx (right). The mass also invaded skull base,
including foramen ovale and foramen rotundum, sphenoid
sinus, both major and minor pterygium of sphenoid bone,
and pterygopalatine fossa. Therefore, biopsy was taken from




Figure 1: MRI image: a large soft tissue mass (arrows) invades the
skull base.
examination. The patient deceased before treatment because
of extensive disease, which led to respiratory failure, apnea,
and heart arrest.
3.MaterialsandMethods
The specimen was ﬁxed in 10% formalin, and sections
were embedded in paraﬃn blocks. Four micron-thick
paraﬃn sections were stained with hematoxylin and eosin.
Unstained paraﬃn sections were used for immunohisto-
chemical stains. The antibody panel included pankeratin
(clone AE1/AE3, DakoCytomation, Glostrup, Denmark),
EMA (clone E29, DakoCytomation, Glostrup, Denmark),
CAM5.2(clone5D3,Novocastra,NewcastleuponTyne,UK),
34βE12 (clone 34βE12, DakoCytomation, Glostrup, Den-
mark), cyclin D1 (clone DSC-6, Novocastra, Newcastle upon
Tyne, UK), EGFR (clone 31G7, Zymed, San Francisco, Calif.,
USA), p53 (clone DO-7, DakoCytomation, Glostrup, Den-
mark), CD20 (clone L26, DakoCytomation, Glostrup, Den-
mark), CD45RA (clone 4KB5, DakoCytomation, Glostrup,
Denmark), CD45RO (clone UCHL1, DakoCytomation,
Glostrup, Denmark), CD3 (clone PS1, Novocastra, Newcas-
tle upon Tyne, UK), CD5 (clone SP19, Spring Bioscience,
Inc),CD23(cloneSP23,SpringBioscience,Inc),CD10(clone
56C6, Novocastra, Newcastle upon Tyne, UK), and BCL6
(clone PG-B6p, DakoCytomation, Glostrup, Denmark).
For detecting possible infection of neoplastic cells by
EBV, we used a chromogenic in situ hybridization technique
(EBER Histosonda, Cenbimo, Lugo, Spain) according to
manufacturer’s instructions. Negative and positive controls
were used to exclude the possibility of nonspeciﬁc staining.
APCRassayforthedetectionofamonoclonalrearrange-
mentoftheimmunoglobulingenewasused.DNAextraction
was obtained from paraﬃn sections, and the PCR technique
Figure 2: Large round or spindle neoplastic cells arranged in
irregular anastomosing islands (HE x200).
Figure3:NeoplasticcellsshowpositivitytokeratinsAE1/AE3(IHC
x400).
was performed in accordance to the BIOMED protocols.
The products were checked with capillary electrophoresis in
geneticanalyzerABI3130.Allreactionswereperformedwith
positive and negative controls for each target.
Translocations t(14;18) and t(11;18) were investigated
by FISH analysis. The commercially available probes for
translocation t(14;18) (LSI IGH/MALT1 t(14;18)(q32;q21)
Dual Color, Dual Fusion Translocation Probe, Vysis, USA)
and t(11;18) (LSI API2/MALT1 t(11;18)(q21;q22) Dual
Color, Dual Fusion Translocation Probe, Vysis, USA) were
used. The procedures were performed according to the
manufacturer’s instructions.
4. Results
Microscopically, neoplastic cellular nests with a reticular
anastomosing pattern were observed. The neoplastic cells
were oval or polygonal with round nuclei and quite often
with prominent nucleoli (Figure 2). On immunohistochem-
ical examination, these cells were positive for keratins
(AE1/AE3, CK8/18, and 34βE12) (Figure 3), EMA, Cyclin
D1, EGFR, and p53. Moreover, the neoplastic cells were
EBER positive by ISH analysis (Figure 4).Pathology Research International 3
Figure 4: EBER-positive neoplastic cells (x400).
Figure 5: Coexistence of nasopharyngeal carcinoma (left) and
MALT-type lymphoma (right) (HE x40).
Close beside the above-mentioned carcinoma, a lym-
phomatous monomorphic population was observed con-
sisting of small-to medium-sized lymphoid cells with pale
cytoplasm and slightly irregular nuclei (Figures 5 and 6). The
lymphoidcellswerelocalizedinthedeepersubmucosaltissue
of hypopharyngeal wall, inﬁltrating the striated muscle cells
(Figure 6). Mitotic ﬁgures were usually few. Immunohisto-
chemical stains demonstrated CD20 and CD45RA positivity,
a ﬁnding consistent with the presence of a B-cell lineage
lymphoma (Figure 7) .T u m o u rc e l l sw e r en e g a t i v ef o rT -
cell markers, such as CD45RO and CD3, although a few
reactive T-cells were scattered among the lymphomatous
population. Stains for CD5, CD10, BCL6, CD23, and Cyclin
D1 were also negative. On PCR analysis a monoclonal IGH
gene rearrangement was detected and neither t(14;18) nor
t(11;18) translocations were found by FISH analysis.
Based on the above histological, immunohistochemical,
and molecular ﬁndings, the diagnosis of nasopharyngeal
undiﬀerentiated carcinoma coexisting with a marginal zone
B-cell lymphoma of MALT-type was set.
Figure 6: Muscle cells inﬁltrated by neoplastic lymphoid popula-
tion (HE x100).
Figure 7: Positivity of neoplastic lymphoid cells to CD20 antibody
(IHC x400).
5. Discussion
Nasopharyngeal carcinoma is a nonlymphomatous, squa-
mous cell carcinoma occurring in the epithelium of the
nasopharynx. According to WHO classiﬁcation [7], this case
belongs to the undiﬀerentiated subtype of nasopharyngeal
carcinoma. The fact that 10% of the patients are asymp-
tomatic or present quiteoftensubtle or nonspeciﬁc signs and
symptomsandthediﬃcultyofmakingaclinicalexamination
of the nasopharynx lead to a delay in diagnosis, resulting in
clinical presentation at an advanced stage of disease [7–9], as
happened in our case.
Subclassiﬁcation of nonkeratinizing nasopharyngeal car-
cinoma into the undiﬀerentiated and diﬀerentiated subtypes
has no clinical or prognostic signiﬁcance [7]. Pathological
ﬁndings include large cells with round or oval nuclei that
show no keratinization. These cells, arranged in solid sheets,
irregular islands, discohesive sheets, and trabeculae, are
frequently intermingled with lymphoid cells. The density of
lymphoid cells varies from scattered to abundant. In case of
prominent nonneoplastic lymphoid component, the term
lymphoepithelioma and more recently lymphoepithelial
carcinoma was used [10]. Neoplastic lymphoid cells in
nasopharyngeal carcinoma have never been described.4 Pathology Research International
Lymphomas of the head and neck region are considered
as a single group based on their topographical localization
in this anatomic area, which is the most common site of
extranodal aﬀection by non-Hodgkin’s lymphomas. How-
ever,MALT-typelymphomasarerareinWaldeyer’sring[11].
Signs and symptoms of a non-Hodgkin’s lymphoma may
be similar to those of squamous cell carcinoma, and the
distinction is made only by biopsy. A respective percentage
ofpatientswithheadandneckMALT-typelymphomahavea
synchronous lymphomatous lesion in another organ [4, 12].
Inthiscase,theimportanceoffacingthenasopharyngealcar-
cinoma and eventually the patient’s decease did not permit
the investigation of multiorgan lymphoma involvement. The
vastmajorityofMALT-typelymphomas,andespeciallythose
in extragastric sites, are negative for translocations t(11;18)
and t(14;18) [13], as noted in this case too.
The coexistence of these two neoplasms raises the
question of a common etiologic factor. Nasopharyngeal
carcinoma has been associated with EBV infection and quite
often, apart from neoplastic epithelial cells, a few scattered
bystander lymphocytes are EBV-positive [7, 9, 14]. EBV
implication in MALT-type lymphoma development remains
doubtful and not well understood [15, 16]. Globally, MALT-
type lymphoma is infrequently associated with EBV [15, 17].
In our case, we could not conclude that EBV infection is the
reason of the MALT-type lymphoma development, since the
neoplastic lymphoid population was EBER negative.
Simultaneous occurrence of carcinoma and MALT-type
lymphoma in the same organ has been more frequently
reported in stomach [18], since H. pylori is considered to
play an aetiological role in both adenocarcinoma and lym-
phoma. In addition, coexistence of carcinoma and MALT-
type lymphoma in other organs has been rarely described
in English literature, including scarce cases of thyroid gland
[19, 20]a n dl i v e r[ 21].
6. Conclusions
Synchronous presence of squamous cell carcinoma and
lymphoma in the head and neck area is extremely rare
[22, 23]. Moreover, to the best of our knowledge, this is
the ﬁrst case of nasopharyngeal carcinoma coexisting with
MALT-type lymphoma. Since nasopharyngeal carcinoma is
quite often accompanied by dense lymphocytic inﬁltration,
we report this case, not only for its rarity but also in
order to be acquainted with this coexistence and avoid any
misinterpretation.
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